Suppr超能文献

人白喉抗毒素第一国际标准品的校准与互换性评估。

Calibration and commutability assessment of the 1st International Standard for Diphtheria Antitoxin Human.

作者信息

Stickings Paul, Rigsby Peter, Coombes Laura, von Hunolstein Christina, Ralli Luisa, Pinto Antonella, Sesardic Dorothea

机构信息

Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK.

出版信息

Biologicals. 2013 Nov;41(6):384-92. doi: 10.1016/j.biologicals.2013.08.001. Epub 2013 Sep 5.

Abstract

The 1st International Standard for Diphtheria Antitoxin Human (coded 10/262) was established by the World Health Organization Expert Committee on Biological Standardization in 2012. This paper describes the production, characterization and calibration of the new standard which is intended for use in the standardization of assays used to measure diphtheria antibody responses in human serum. The new standard was calibrated in terms of the International Standard for Diphtheria Antitoxin Equine in an international collaborative study. A total of 8 participants from 8 different countries performed in vivo and/or in vitro toxin neutralization tests and returned data that was used to assign units to the proposed new standard. The new standard has a diphtheria antitoxin potency of 2 IU/ampoule and is predicted to be stable. A follow up study was performed to assess commutability of the new standard. The follow up study was an existing external quality assessment, modified to include the new standard. Results obtained suggest that the new standard is commutable, showing comparable behaviour to native human serum samples in the majority of the assays compared, and is therefore suitable for use as a reference preparation in assays used to measure the level of anti-diphtheria antibodies in human serum.

摘要

《人源白喉抗毒素国际标准品(编号10/262)》于2012年由世界卫生组织生物标准化专家委员会制定。本文描述了该新标准的生产、特性鉴定和校准情况,其旨在用于标准化检测人血清中白喉抗体反应的分析方法。在一项国际协作研究中,根据马源白喉抗毒素国际标准品对该新标准进行了校准。来自8个不同国家的8名参与者进行了体内和/或体外毒素中和试验,并返回了用于为提议的新标准赋值的数据。该新标准的白喉抗毒素效价为2 IU/安瓿,预计稳定性良好。开展了一项后续研究以评估新标准的互换性。该后续研究是一项现有的外部质量评估,经修改后纳入了新标准。所得结果表明,该新标准具有互换性,在大多数比较分析中与天然人血清样本表现出相似特性,因此适用于作为检测人血清中抗白喉抗体水平的分析方法的参考制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验